Metacross Otw
Device Lesion Therapy
PDI 04540778154414
General payments
$491,025
Research payments
$0
Through program year 2025, $491,025 in general payments and $0 in research payments were reported against Metacross Otw (Lesion Therapy).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $55,001 | 699 |
| 2024 | General | $27,748 | 635 |
| 2023 | General | $46,476 | 533 |
| 2022 | General | $196,198 | 737 |
| 2021 | General | $165,603 | 743 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 31 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 43 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
3,347 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.